- RTW Venture Fund Limited announced that Abdera Therapeutics has completed its $142M Series A and Series B financing rounds in which it participated. Abdera is a privately held pre-clinical stage biopharmaceutical company leveraging antibody engineering to design and develop new precision radiopharmaceuticals for cancer. The company is building a pipeline of potentially best-in-class therapies for both clinically validated and novel targets that deliver potent radioisotopes capable of emitting alpha or beta particles to selectively destroy cancer cells.
- Greencoat UK Wind PLC announced that it has published its ESG Report for 2022 which is available on the company’s website.
We also have a trading update from Oakley Capital, and CT Property Trust, and annual results for Aquila European Renewables, RM Infrastructure Income, M&G Credit Income, and Third Point Investors